准确测量和定量相关基质中可提示临床药物开发的许多方面的生物标志物。生物标志物分析可以为患者匹配合适的治疗,并证明候选药物的安全性和疗效,从而揭示其临床和商业成功的可能性。Q2 Solutions 提供广泛的定制和整合液相色谱质谱服务,以支持生物标志物测定和定量,包括液质联用 (LC/MS) 生物分析、LC/MS/MS 分析、混合 LC-MS 测定、小分子 LC/MS 和大分子生物分析。
There is an increase in the complexity of drug modalities along with the need for more sensitive methods. Immunoassays, while often chosen as the first platform to utilize for assessing...
Translational research programs have been created to provide a better understanding of disease susceptibilities and pathway mechanisms. These programs require integration and analysis of multiple...
Learn more about Merck’s Biospecimen and Biorepository Management System (BBMS) - a transformational informatics project that improves operational visibility, increases efficiency, and maintains...